Research Articles

Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.

stats1
stats2
stats3
stats4

Search for:

     Vitamin E
539 records.
Article ID PMID Source Title Publish Year
A47423 7615205 Gastroenterology Dietary saturated fatty acids: a novel treatment for alcoholic liver disease. 1995 Details
A47961 28077381 Am J Clin Nutr Metabolic syndrome increases dietary α-tocopherol requirements as assessed using urinary and plasma vitamin E catabolites: a double-blind, crossover clinical trial. 2017 Details
A48018 26447154 Am J Clin Nutr α-Tocopherol bioavailability is lower in adults with metabolic syndrome regardless of dairy fat co-ingestion: a randomized, double-blind, crossover trial. 2015 Details
A48042 25866507 Gastroenterol Res Pract Treatment of nonalcoholic steatohepatitis in adults: present and future. 2015 Details
A48156 21107760 Curr Gastroenterol Rep Clinical trial report: treatment of nonalcoholic steatohepatitis with vitamin E. 2011 Details
A48165 20857543 N Engl J Med Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. 2010 Details
A48166 20855789 Ann Intern Med ACP Journal Club: vitamin E, but not pioglitazone, improved nonalcoholic steatohepatitis in nondiabetic patients. 2010 Details
A48168 20843257 N Engl J Med Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. 2010 Details
A48173 20683969 Hepatology Vitamin E for nonalcoholic steatohepatitis: ready for prime time? 2010 Details
A48351 15625648 Clin Gastroenterol Hepatol Treatment of nonalcoholic steatohepatitis: antioxidants or insulin sensitizers? 2004 Details
A48354 15570868 Nihon Shokakibyo Gakkai Zasshi [Treatment of nonalcoholic steatohepatitis (NASH)]. 2004 Details
A48365 15135345 Hepatol Res Control of oxidative stress and reduction in biochemical markers by Vitamin E treatment in patients with nonalcoholic steatohepatitis: a pilot study. 2004 Details
A48574 33783748 Adv Exp Med Biol Extensive Bioactivity of Astaxanthin from Haematococcus pluvialis in Human. 2021 Details
A48843 26773358 Environ Toxicol Pharmacol Protective effects of carnosine alone and together with alpha-tocopherol on lipopolysaccharide (LPS) plus ethanol-induced liver injury. 2015 Details
A48872 25954093 World J Gastroenterol Role of vitamins in gastrointestinal diseases. 2015 Details
A48889 25509693 J Med Assoc Thai Effects of vitamin E on chronic hepatitis C genotype 3: a randomized, double-blind, placebo-controlled study. 2014 Details
A49064 19594730 Basic Clin Pharmacol Toxicol Progression of lipid peroxidation measured as thiobarbituric acid reactive substances, damage to DNA and histopathological changes in the liver of rats subjected to a methionine-choline-deficient diet. 2009 Details
A49144 16296871 Drugs Pathophysiological basis for antioxidant therapy in chronic liver disease. 2005 Details
A49145 16289367 Med Hypotheses Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): The other face of the coin of histology. 2005 Details
A49230 35814516 J Clin Exp Hepatol Pharmacotherapeutic Impact on Nonalcoholic Steatohepatitis Histology: A Systematic Review and Network Meta-analysis. 2022 Details
A49296 35796150 J Intern Med Current treatment of non-alcoholic fatty liver disease. 2022 Details
A49367 35775425 Clin Sci (Lond) Early biochemical observations point to nutritional strategies to manage non-alcoholic fatty liver disease. 2022 Details
A49900 35603860 Nutr Health Decreased Serum zinc, selenium, and vitamin E as possible risk factors of hepatic fibrosis in non-alcoholic fatty liver disease. 2022 Details
A49905 35602098 Oxid Med Cell Longev A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases. 2022 Details
A49933 35589613 Diabetes Obes Metab Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications. 2022 Details
A50136 35507280 Curr Atheroscler Rep Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease. 2022 Details
A50386 35409028 Int J Mol Sci SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease. 2022 Details
A50529 35352691 Eur J Gastroenterol Hepatol Nonalcoholic fatty liver disease: opinions, population served, and management from a sample of French hepato(gastroentero)logists (PERSEPT study). 2022 Details
A50717 35288522 Am J Gastroenterol Dietary Vitamin E Intake Is Associated With a Reduced Risk of Developing Digestive Diseases and Nonalcoholic Fatty Liver Disease. 2022 Details
A50721 35287643 BMC Endocr Disord Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. 2022 Details
A50745 35280867 Front Med (Lausanne) Efficacy of Off-Label Therapy for Non-alcoholic Fatty Liver Disease in Improving Non-invasive and Invasive Biomarkers: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. 2022 Details
A51349 35400820 J Clin Biochem Nutr Effect of tocotrienol on the primary progression of nonalcoholic steatohepatitis in a mouse model. 2021 Details
A51462 33989565 Cell Chem Biol Endogenous vitamin E metabolites mediate allosteric PPARγ activation with unprecedented co-regulatory interactions. 2021 Details
A51478 30556637 IUBMB Life Vitamin E: Regulatory Role on Signal Transduction. 2018 Details
A52568 25518445 Avian Dis Liver pathology associated with increased mortality in turkey breeder and meat turkey flocks. 2014 Details
A52636 24425726 Adv Nutr Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease. 2014 Details
A52770 22226887 Biochim Biophys Acta Oxidative stress and antioxidant therapy in cystic fibrosis. 2011 Details
A53014 17466100 Proc Nutr Soc The interplay between nutrients and the adipose tissue. 2007 Details
A53109 12901271 Wiad Lek [Alcoholic liver disease]. 2003 Details